DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mirapex (Pramipexole Dihydrochloride) - Current Clinical Trials

 
 



Mirapex Related Clinical Trials

Pramipexole as a Treatment for Cocaine Dependence [Completed]

Pramipexole for Binge Eating Disorder [Withdrawn]

Study to Observe the Effect of Mirapex ER« Once-daily (QD) Versus Twice-daily (BID) [Recruiting]

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) [Completed]

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) [Completed]

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease [Completed]

Pramipexole Conversion to Ropinirole Controlled Release (CR) [Completed]

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride [Completed]

Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor [Not yet recruiting]

In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers [Completed]

Dexpramipexole and Cimetidine Drug Drug Interaction (DDI) [Completed]

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions [Completed]

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions [Completed]

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome [Recruiting]

Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers [Completed]

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate) [Completed]

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD [Completed]

Post Marketing Surveillance And Special Surveillance for Mirapex« Tablet in Patients With Idiopathic Parkinson's Disease [Completed]

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease [Recruiting]

Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia [Recruiting]

Targeting Cognition in Bipolar Disorder With Pramipexole [Recruiting]

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease [Completed]

Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers [Completed]

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period [Completed]

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson┬┤s Disease (PD). [Completed]

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome [Terminated]

Safety and Efficacy of Long-term Daily Use of Mirapex«-LA Tablets in Patients With Parkinson's Disease [Completed]

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) [Completed]

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) [Completed]

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients [Completed]

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. [Completed]

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance [Completed]

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients [Completed]

Lexapro and Pramipexole and to Treat Major Depression [Completed]

Dexpramipexole SAD/MAD Study [Completed]

Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects [Completed]

Effectiveness of Pramipexole for Treatment-Resistant Depression [Completed]

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole [Completed]

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS [Completed]

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients [Completed]

Efficacy and Tolerability of Sifrol´┐Ż (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease [Completed]

Observational Study of Sifrol´┐Ż in Patients With Primary Restless Legs Syndrome (RLS) [Completed]

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder [Not yet recruiting]

Dexpramipexole Renal PK Study [Completed]

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study [Completed]

Observational Study of Sifrol« in Patients With Primary Restless Legs Syndrome (RLS) [Completed]

Post Marketing Surveillance Study of Sifrol« in Patients With Idiopathic Parkinson's Disease [Completed]

Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers [Completed]

Pramipexole ER vs. Placebo in Fibromyalgia [Terminated]

Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers [Completed]

Imaging Dopamine Release in Depression [Recruiting]

Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients [Completed]

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS) [Completed]

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients [Completed]

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients [Completed]

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole [Completed]

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms [Completed]

Cognitive Enhancement in Bipolar Disorder [Completed]

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS [Completed]

Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease [Completed]

Dexpramipexole Japanese PK Study [Completed]

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS) [Completed]

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients [Completed]

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis [Completed]

Phase 3 Study of Dexpramipexole in ALS [Completed]

Phase 3 Extension Study of Dexpramipexole in ALS [Terminated]

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) [Completed]

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease [Completed]

Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria [Completed]

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease [Completed]

Pramipexole (BI-Sifrol«) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome [Completed]

Pivotal Study in Advanced Parkinsons Disease Patients [Completed]

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson┬┤s Disease [Completed]

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment [Completed]

Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar« DR) in Patients With Restless Legs Syndrome [Completed]

Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome [Completed]

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome [Recruiting]

Clinical Trial of Pramipexole in Bipolar Depression [Completed]

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia [Completed]

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) [Completed]

Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers [Completed]

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease [Completed]

Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole [Completed]

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients [Completed]

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances [Completed]

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS [Completed]

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease [Completed]

Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day [Temporarily not available]

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) [Completed]

The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study) [Terminated]

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease [Terminated]

Tolerability of Sifrol« in Ambulatory Patients Suffering From Parkinson's Disease [Completed]

The Effect of Sifrol« on Tremor and Depression in Patients With Idiopathic Parkinson's Disease [Completed]

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease [Completed]

Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors [Completed]

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease [Completed]

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017